C248 Pill - beige capsule/oblong
Pill with imprint C248 is Beige, Capsule/Oblong and has been identified as Darunavir Hydrate 600 mg (base). It is supplied by Cipla USA, Inc.
Darunavir is used in the treatment of HIV Infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Darunavir 600 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for C248
Darunavir Hydrate
- Imprint
- C248
- Strength
- 600 mg (base)
- Color
- Beige
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- National Drug Code (NDC)
- 69097-0248
More about darunavir
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: protease inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
